3-methoxytyramine has been researched along with Substance-Related Disorders in 1 studies
3-methoxytyramine: RN given refers to parent cpd
3-methoxytyramine : A monomethoxybenzene that is dopamine in which the hydroxy group at position 3 is replaced by a methoxy group. It is a metabolite of the neurotransmitter dopamine and considered a potential biomarker of pheochromocytomas and paragangliomas.
Substance-Related Disorders: Disorders related to substance use or abuse.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yui, K | 1 |
| Ishiguro, T | 1 |
| Goto, K | 1 |
| Ikemoto, S | 1 |
| Kamata, Y | 1 |
1 trial available for 3-methoxytyramine and Substance-Related Disorders
| Article | Year |
|---|---|
Spontaneous recurrence of methampetamine psychosis: increased sensitivity to stress associated with noradrenergic hyperactivity and dopaminergic change.
Topics: Adaptation, Psychological; Adult; Analysis of Variance; Dopamine; Female; Humans; Methamphetamine; N | 1999 |